Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Naima Ali Al-Mulla"'
Autor:
Mahmoud M. Elzembely, Abdulhakim Al Rawas, Abdulqader Al-Hebshi, Abdulrahman Alhadi, Ahmed K. Ibrahim, Amal Ahmed Zein, Iman Ragab, Eman Taryam Alshamsi, Enas Dammag, Fatiha Gachi, Gamal Hussien Zain, Hadeel Saleh Mohammad, Hisham Haddad, Houda Boudiaf, Ibrahim Alharbi, Iyad Sultan, Khadra Hasan Salami, Mohamed S. Bayoumy, Naima Ali Al-Mulla, Nawal Al Mashaikhi, Rami Mohammed Almajali, Roula Farah, Saad A. Al Daama, Salah Ahmad, Seham M. Ragab, Shady H. Fadel, Soha Ahmed, Suleimman Al-Sweedan, Suzy Abdelmabood, Waleed Khaled Kaleem, Youssef Madney
Publikováno v:
Journal of Pediatric Hematology/Oncology. 45:e87-e91
During the COVID-19 pandemic, major challenges are facing pediatric cancer centers regarding access to cancer centers, continuity of the anti-cancer therapy, hospital admission, and infection protection precautions. Pediatric oncologists actively tre
Autor:
Jens Peter Schenk, Andreas E. Kulozik, Olaf Witt, Patrick Günther, Susanne Hämmerling, Clemens Stockklausner, Wolfgang Behnisch, Bajes Hamad, Naima Ali Al Mulla
Publikováno v:
Journal of pediatric hematology/oncology. 31(4)
A 9-month-old girl presented with massive bilateral diffuse nephroblastomatosis. After response to actinomycin D and vincristine over a period of 1 year, the nephroblastomatosis continuously progressed under this treatment. As retinoic acid signaling
Autor:
Wolfgang Behnisch, Mohammed S. Bessisso, Andreas E. Kulozik, Florian Ertle, Gunhild Mechtersheimer, Dietz Rating, Barbara Hero, Naima Ali Al Mulla
Publikováno v:
Pediatric bloodcancer. 50(3)
Opsoclonus-myoclonus-ataxia-syndrome (OMS) represents a rare neuroblastoma-associated paraneoplastic syndrome that commonly results in neurologic deficits despite tumor resection and immunosuppressive therapy. We describe the response of five such ch
Autor:
Andreas E. Kulozik, Niels H. Gehring, Naima Ali Al Mulla, Clemens Stockklausner, Nicole Echner
Publikováno v:
Blood. 112:890-890
Thrombopoiesis is tightly regulated by the interaction between thrombopoietin (TPO) and its receptor c-Mpl. Ligand binding results in dimerization of the receptor, internalization of the complex, and activation of downstream signaling. This activatio